Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2025-2033

Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6148

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Insomnia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapy Type
    6.1    Non-Pharmacological Therapy
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Hypnotherapy
           6.1.2.2 Cognitive Behavioral Therapy
           6.1.2.3 Medical Devices
           6.1.2.4 Others
        6.1.3 Market Forecast
    6.2    Pharmacological Therapy
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Prescription Sleep Aids
           6.2.2.2 Over-The-Counter Sleep Aids
        6.2.3 Market Forecast
7   Market Breakup by Drug Class
    7.1    Antidepressants
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Melatonin Antagonist
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Benzodiazepines
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Nonbenzodiazepines
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Orexin Antagonist
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Drug Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Online Pharmacies
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Astellas Pharma Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Aurobindo Pharma Limited
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Biocodex
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Eisai Co. Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Mallinckrodt Pharmaceuticals
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Neurim Pharmaceuticals Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Vanda Pharmaceuticals Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials

List of Figures

Figure 1: Global: Insomnia Market: Major Drivers and Challenges
Figure 2: Global: Insomnia Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2024
Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2024
Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2024
Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2024
Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Global: Insomnia Industry: SWOT Analysis
Figure 82: Global: Insomnia Industry: Value Chain Analysis
Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Insomnia Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Insomnia Market: Competitive Structure
Table 7: Global: Insomnia Market: Key Players

Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials